Abstract:ABSTRACT Gut dysbiosis is closely related to dysregulated microRNAs (miRNAs) in the intestinal epithelial cells, which plays an important role in the pathogenesis of Crohn’s disease (CD). We investigated the relationship between fecal gut microbiome (GM) and intestinal tissue miRNAs in different stages of pediatric CD. Metagenomic analysis and miRNA sequencing were conducted to examine the GM and intestinal miRNA profiles of CD patients before and after clinical induction therapy and the controls. Twenty-seven newly diagnosed, therapy-naïve pediatric patients with active CD and 11 non-inflammatory bowel disease (IBD) controls were recruited in this study. Among CD patients, 11 patients completed induction treatment and reached clinical remission. Both GM and miRNA profiles were significantly changed between CD patients and controls. Seven key bacteria were identified at species level including Defluviitalea raffinosedens , Thermotalea metallivorans , Roseburia intestinalis , Dorea sp. AGR2135, Escherichia coli , Shigella sonnei , and Salmonella enterica , the exact proportions of which were further validated by real-time quantitative PCR analysis. Eight key miRNAs were also identified including hsa-miR-215-5p, hsa-miR-194-5p, hsa-miR-12135, hsa-miR-509-3-5p, hsa-miR-212-5p, hsa-miR-4448, hsa-miR-501-3p, and hsa-miR-503-5p. The functional enrichment analysis of differential miRNAs indicated the significantly altered cyclin protein, cyclin-dependent protein, and cell cycle pathway. The close interactions between seven key bacteria and eight key miRNAs were further investigated by miRNA target prediction. The association between specific miRNA expressions and key gut bacteria at different stages of CD supported their important roles as potential molecular biomarkers. Understanding the relationship between them will help us to explore the molecular mechanisms of CD. IMPORTANCE Since previous studies have focused on the change of the fecal gut microbiome and intestinal tissue miRNA in pediatric Crohn’s disease (CD), the relationship between them in different stages is still not clear. This is the first study to explore the gut microbiota and miRNA and their correlations with the Pediatric Crohn’s Disease Activity Index (PCDAI). Crohn’s Disease Endoscopic Index of Severity (CDEIS), and calprotectin, by applying two omics approach in three different groups (active CD, CD in remission with exclusive enteral nutrition or infliximab induction therapy, and the healthy controls). Both gut microbiome structure and the miRNA profiles were significantly changed in the different stage of CD. Seven key gut microbiome at species and eight key miRNAs were found, and their close interactions were further fully investigated by miRNA target prediction.

Expression Alteration of Long Non-Coding RNAs and Their Target Genes in the Intestinal Mucosa of Patients with Crohn’s Disease

Profiling the Lncrna-Mirna-mrna Cerna Network to Reveal Potential Crosstalk Between Inflammatory Bowel Disease and Colorectal Cancer

Lncrnacnn3-206 Activates Intestinal Epithelial Cell Apoptosis and Invasion by Sponging Mir-212, an Implication for Crohn's Disease

Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease

The role of long non-coding RNA in Crohn's disease

Plasma Long Noncoding RNA Expression Profile Identified by Microarray in Patients with Crohn's Disease.

Altered Microrna Expression in Inflamed and Non-Inflamed Terminal Ileal Mucosa of Adult Patients with Active Crohn'S Disease

A Novel Strategy to Identify Mrna 3′ UTR and Mrna Level Difference in Crohn’s Disease

Circular RNA Expression Alterations in Colon Tissues of Crohn's Disease Patients

LINC01272 Activates Epithelial-Mesenchymal Transition Through Mir-153-5p in Crohn’s Disease

CD177+ Neutrophils and Its Correlation with Mucosal Impairment in Patients with Inflammatory Bowel Disease

Nonlesional ileal transcriptome in Crohn's disease reveals alterations in immune response and metabolic pathway

Role of miRNAs in pathogenesis of inflammatory bowel disease

LINC01272 Activates Epithelial-Mesenchymal Transition Through Mir-153-5p in Crohn's Disease.

LncRNA-miRNA-mRNA Network Analysis Reveals the Potential Biomarkers in Crohn’s Disease Rats Treated with Herb-Partitioned Moxibustion

Role of long non-coding RNA in inflammatory bowel disease

Construction, bioinformatics analysis, and validation of competitive endogenous RNA networks in ulcerative colitis

P002 Regulation of miR-338-3p and miR-378a-3p in the intestinal mucosa of Crohn’s disease: Potential targets for modulating inflammation

Transcriptomic landscape of lncRNAs in inflammatory bowel disease

PLGA microspheres carrying miR-20a-5p improved intestinal epithelial barrier function in patients with Crohn's disease through STAT3-mediated inhibition of Th17 differentiation

Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease